Citigroup’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-173,037
| Closed | -$23.7M | – | 7989 |
|
|
2018
Q2 | $23.7M | Buy |
173,037
+142,566
| +468% | +$12.9M | 0.02% | 707 |
|
|
2018
Q1 | $2.4M | Buy |
30,471
+23,510
| +338% | +$1.73M | ﹤0.01% | 2443 |
|
|
2017
Q4 | $475K | Sell |
6,961
-2,862
| -29% | -$148K | ﹤0.01% | 4147 |
|
|
2017
Q3 | $395K | Sell |
9,823
-6,139
| -38% | -$237K | ﹤0.01% | 4343 |
|
|
2017
Q2 | $634K | Buy |
15,962
+13,146
| +467% | +$481K | ﹤0.01% | 3766 |
|
|
2017
Q1 | $91K | Sell |
2,816
-6,222
| -69% | -$155K | ﹤0.01% | 5277 |
|
|
2016
Q4 | $160K | Buy |
9,038
+1,064
| +13% | +$22.9K | ﹤0.01% | 5467 |
|
|
2016
Q3 | $185K | Buy |
7,974
+1,536
| +24% | +$34.9K | ﹤0.01% | 4722 |
|
|
2016
Q2 | $120K | Sell |
6,438
-2,436
| -27% | -$44K | ﹤0.01% | 4936 |
|
|
2016
Q1 | $161K | Buy |
8,874
+2,538
| +40% | +$40.9K | ﹤0.01% | 5292 |
|
|
2015
Q4 | $133K | Buy |
6,336
+3,484
| +122% | +$67.1K | ﹤0.01% | 5111 |
|
|
2015
Q3 | $53K | Sell |
2,852
-5,821
| -67% | -$145K | ﹤0.01% | 5406 |
|
|
2015
Q2 | $293K | Buy |
8,673
+3,595
| +71% | +$145K | ﹤0.01% | 4145 |
|
|
2015
Q1 | $245K | Sell |
5,078
-4,837
| -49% | -$219K | ﹤0.01% | 4343 |
|
|
2014
Q4 | $220K | Buy |
9,915
+7,815
| +372% | +$180K | ﹤0.01% | 4606 |
|
|
2014
Q3 | $40K | Buy |
2,100
+402
| +24% | +$9.59K | ﹤0.01% | 5464 |
|
|
2014
Q2 | $46K | Buy |
1,698
+532
| +46% | +$13.5K | ﹤0.01% | 5221 |
|
|
2014
Q1 | $38K | Sell |
1,166
-3,216
| -73% | -$105K | ﹤0.01% | 5670 |
|
|
2013
Q4 | $104K | Buy |
+4,382
| New | +$122K | ﹤0.01% | 5230 |
|
Citigroup's FMI Position: Q3 2018 in Review
Citigroup sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 173,037 shares — an estimated $23.7M sold.
Citigroup first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $23.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Citigroup reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Citigroup sold 173,037 Foundation Medicine, Inc. shares in Q3 2018, an estimated $23.7M.
- Citigroup first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- Citigroup's Foundation Medicine, Inc. position peaked at $23.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Citigroup's 13F filing for Q3 2018, filed 13 Nov 2018.